Layton Patrick Mills
Founder bij CANNPAL ANIMAL THERAPEUTICS LIMITED
Profiel
Layton Patrick Mills is the founder of CannPal Animal Therapeutics Ltd., a company founded in 2016.
He holds the title of Chief Executive Officer, Director & MD at CannPal Animal Therapeutics Ltd.
Currently, Mr. Mills is a Non-Executive Director at Argent BioPharma Ltd., a position he started in 2023.
In the past, he served as the Chief Executive Officer at AusCann Group Holdings Ltd.
from 2021 to 2022.
Actieve functies van Layton Patrick Mills
| Bedrijven | Functie | Begin |
|---|---|---|
| CANNPAL ANIMAL THERAPEUTICS LIMITED | Founder | 03-06-2016 |
| ARGENT BIOPHARMA LIMITED | Director/Board Member | 01-06-2023 |
Eerdere bekende functies van Layton Patrick Mills
| Bedrijven | Functie | Einde |
|---|---|---|
| AUSCANN GROUP HOLDINGS LTD | Chief Executive Officer | 13-09-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ARGENT BIOPHARMA LIMITED | Health Technology |
| AUSCANN GROUP HOLDINGS LTD | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
CannPal Animal Therapeutics Ltd.
 CannPal Animal Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology CannPal Animal Therapeutics Ltd. pharmaceutical company, which focuses on animal health. It researches, develops, and commercializes regulatory approved cannabinoid-derived therapeutic pet products for cats and dogs. The company was founded by Layton Mills on June 3, 2016 and is headquartered in Double Bay, Australia. | Health Technology |
